Partners4Access, the global access experts for orphan drugs, has entered into a collaboration with Cambridge University to support their Graduate Professional Practice Programme.
Partners4Access will support a student from the Masters in Bioscience Enterprise program develop their dissertation, providing a platform to engage in a corporate-level environment.
Sophie Schmitz, Managing Partner at Partners4Access said, “We are delighted with the collaboration with Cambridge University. This program will provide a great opportunity to help students on the Graduate Professional Practice Programme understand the real-world demands of a global consultancy, within the context of today’s challenging access environment. We will support the Programme from our European HQ in London.’’
Each student in this programme will work with Parners4Access on a specific topic gaining experience in areas such as primary research, value development and improve knowledge about the global pharmaceutical industry.
Partners4Access is a global consultancy 100% focused on orphan drug access. The company support the biotechnology and pharmaceutical industry along their launch journey to help secure successful price, reimbursement and access for orphan drugs.